Welcome to our dedicated page for Alignment Healthcare SEC filings (Ticker: ALHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Alignment Healthcare, Inc.'s SEC filings document a Medicare Advantage operating company with common stock listed on Nasdaq under ALHC. Its Form 8-K reports furnish quarterly and annual operating results, health plan membership, revenue, adjusted gross profit, adjusted EBITDA, guidance updates and Regulation FD materials related to strategy, market position and Medicare Advantage quality ratings.
Proxy materials cover board elections, executive compensation, equity awards, pay-versus-performance data and shareholder voting matters. Registration statements, prospectus supplements and underwriting agreements describe secondary offerings of common stock by selling stockholders, the company's capital structure and related securities-law obligations.
Alignment Healthcare, Inc. President Dawn Christine Maroney reported insider transactions in common stock. She sold 30,000 shares in an open-market sale at a weighted-average price of $16.0855 per share under a Rule 10b5-1 plan adopted on 05/22/25. She also made bona fide gifts totaling 21,500 shares to a family member and a charitable donor advised fund. After these transactions, she directly holds 977,313 shares.
General Atlantic and affiliated entities report shared beneficial ownership of 308,852 shares of Alignment Healthcare, Inc. Class A common stock. The filing states the Reporting Persons may be deemed to beneficially own 308,852 shares, representing 0.1% of the company's 206,733,823 shares outstanding as of April 27, 2026. The ownership is held across multiple General Atlantic entities and the GA Funds; voting and dispositive power are reported as shared.
Alignment Healthcare, Inc. ownership disclosure: Wellington Management affiliates report beneficial ownership of 17,098,936 shares of common stock, representing 8.37% of the class as stated in this Schedule 13G/A (cover shows 03/31/2026). The filing lists shared voting power of 14,895,474 shares and shared dispositive power of 17,098,936 across named Wellington entities. The submission identifies the reporting entities and parent/subsidiary relationships and is signed by a Compliance Manager on behalf of the Wellington filers.
Alignment Healthcare, Inc. director and Chief Executive Officer John E. Kao reported open-market sales of a total of 298,000 shares of common stock on May 11, 2026 through an entity associated with him. The transactions were executed at weighted-average prices of $16.8494 and $17.5350 per share, across ranges from $16.22 to $17.70. According to a footnote, the sold shares are held by the JEK Trust, dated February 8, 2021, for which Mr. Kao serves as trustee. Following these sales, an indirect holding entry shows 1,508,641 shares and a separate direct holding entry shows 1,784,868 shares owned after the reported transactions. A footnote also provides the date of a Rule 10b5-1 plan adoption as November 21, 2025.
Alignment Healthcare, Inc. reported governance and leadership changes. On May 6, 2026, its board amended the Amended and Restated Bylaws to formally add the position of Vice Chair of the Board, who presides over board meetings when the Chairman is absent.
Founder and CEO John Kao has been named Chairman of the Board while continuing as CEO, keeping strategic leadership centralized. Former Chairman Joseph Konowiecki becomes Vice Chairman and Executive Vice President of Corporate Affairs, overseeing Human Resources, Legal and Communications. Mark Kent joins as President of the Management Services Organization, and Shane Hochradel becomes Chief Operations Officer, both reporting to Kao.
Issuer filed a Form 144 disclosing proposed sales and recent dispositions of Common Stock. The filing lists 596,000 shares originally issued pre-IPO in exchange for partnership units. It also itemizes multiple 10b5-1 plan and individual sales in March–April 2026, including 250,000 shares sold on 04/07/2026 for $5,252,900.
Alignment Healthcare, Inc. reported strong growth for the three months ended March 31, 2026, moving to profitability while expanding membership. Total revenues rose 33.3% year over year to $1.24 billion, driven mainly by earned premiums of $1.23 billion.
Health plan membership grew 30.9% to 284,800 members. The medical benefits ratio was 88.2%, essentially flat versus 88.4% a year earlier, indicating the company absorbed rapid growth without materially higher medical cost ratios.
Income from operations improved to $15.5 million from a loss of $5.4 million, and net income reached $11.4 million compared with a net loss of $9.4 million. Diluted net income per share was $0.05, versus a diluted loss per share of $0.05 in the prior-year period.
Adjusted metrics also strengthened: Adjusted EBITDA increased 87.6% to $37.9 million and adjusted gross profit rose 36.1% to $145.9 million. The company ended the period with $705.6 million of cash and cash equivalents, long-term debt of $323.6 million (carrying value), and total stockholders’ equity of $206.9 million.
Alignment Healthcare, Inc. reported strong results for the first quarter ended March 31, 2026, highlighted by rapid growth and a return to profitability. Total revenue reached $1,235.2 million, up 33.3% year-over-year, driven by Medicare Advantage expansion.
Health plan membership rose to approximately 284,800 members, a 30.9% increase. Adjusted gross profit was $145.9 million, up 36.1%, and income from operations was $15.5 million. The medical benefits ratio based on adjusted gross profit improved to 88.2%, reflecting better cost control.
Adjusted EBITDA was $37.9 million with a 3.1% margin, up 87.6% year-over-year, while net income was $11.4 million, compared to a $9.4 million net loss a year earlier. For 2026, the company guides to revenue of $5,160–$5,205 million and adjusted EBITDA of $138–$163 million, along with continued membership growth.
BlackRock, Inc. reports beneficial ownership of 13,596,565 shares (representing 6.7%) of Alignment Healthcare, Inc. common stock. The filing, a Schedule 13G/A, attributes these holdings to certain Reporting Business Units of BlackRock and shows sole voting power for 13,305,682 shares as of 03/31/2026.
The cover lists CUSIP 01625V104 and the filing is signed by Spencer Fleming as Managing Director on 04/24/2026.